METABOLON @
2024 AAPS National Biotechnology Conference
- San Francisco, USA
- Booth 801
- May 13 - May 16, 2024
Metabolon is excited to exhibit at the 2024 AAPS National Biotechnology Conference in San Francisco, California.
This conference will feature two tracks, one for the advances in discovery, formulation, and delivery of new modalities, and another for novel strategies advance biotherapeutic development. This conference aims to bring together premier speakers to discuss the pivotal advancements in drug development.
Metabolomics can be used to gain a deeper understanding of the disease mechanisms at a molecular level and identify metabolic changes associated with various disease states, which can provide insights into potential biomarkers and drug targets. Metabolomics can also be used to evaluate pharmacokinetics and pharmacodynamics properties of a drug which can elucidate treatment reseponse and off target effects. Join us at the AAPS National Biotechnology Conference to learn more about how metabolomics can be a powerful tool to aid in your drug development pipeline.
For more event information, you can read visit the official event website or read the official program.
Join us at Booth 801
Join us at booth 801 to discover how Metabolon’s metabolomics services can advance your vision research. Schedule a meeting here to guarantee 1:1 time with a metabolomics expert.
Event Location
Hilton San Francisco Union Square,
333 O’Farrell Street,
San Francisco,
California,
94102
Google Maps
Drug Target Tools: How Metabolomics Reduces Risk in Drug Development
The insights provided by biomarkers also enrich powerful model-based drug discovery. This book will focus on using metabolomics throughout the R&D process as an ally to improve clinical success.
